We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Tender is the day

7 June 2007 By Rob Cox

For years, confusion over the best price rule kept this fast and efficient takeover tool virtually off limits. SEC reforms changed that. As the $11.4bn Biomet deal shows, this can expedite deals and get round pesky proxy advisors. So is this good or bad for investors?

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)